These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 2111982

  • 1. A randomized clinical trial of prophylactic OKT3 monoclonal antibody in liver allograft recipients.
    Cosimi AB, Jenkins RL, Rohrer RJ, Delmonico FL, Hoffman M, Monaco AP.
    Arch Surg; 1990 Jun; 125(6):781-4; discussion 785. PubMed ID: 2111982
    [Abstract] [Full Text] [Related]

  • 2. OKT3 prophylaxis in liver transplantation.
    McDiarmid SV, Millis MJ, Terasaki PI, Ament ME, Busuttil RW.
    Dig Dis Sci; 1991 Oct; 36(10):1418-26. PubMed ID: 1833167
    [Abstract] [Full Text] [Related]

  • 3. Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation.
    Millis JM, McDiarmid SV, Hiatt JR, Brems JJ, Colonna JO, Klein AS, Ashizawa T, Hart J, Lewin K, Goldstein LI.
    Transplantation; 1989 Jan; 47(1):82-8. PubMed ID: 2521409
    [Abstract] [Full Text] [Related]

  • 4. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3.
    Renlund DG, O'Connell JB, Gilbert EM, Hammond ME, Burton NA, Jones KW, Karwande SV, Doty DB, Menlove RL, Herrick CM.
    Transplantation; 1989 Apr; 47(4):599-605. PubMed ID: 2523099
    [Abstract] [Full Text] [Related]

  • 5. Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation.
    Macris MP, Frazier OH, Lammermeier D, Radovancevic B, Duncan JM.
    J Heart Transplant; 1989 Apr; 8(4):281-7. PubMed ID: 2504894
    [Abstract] [Full Text] [Related]

  • 6. Anti-CD3 monoclonal antibody induction therapy. Immunological equivalency with triple-drug therapy in heart transplantation.
    Barr ML, Sanchez JA, Seche LA, Schulman LL, Smith CR, Rose EA.
    Circulation; 1990 Nov; 82(5 Suppl):IV291-4. PubMed ID: 2121387
    [Abstract] [Full Text] [Related]

  • 7. The long-term outcome of OKT3 compared with cyclosporine prophylaxis after liver transplantation.
    McDiarmid SV, Busuttil RW, Levy P, Millis MJ, Terasaki PI, Ament ME.
    Transplantation; 1991 Jul; 52(1):91-7. PubMed ID: 1858160
    [Abstract] [Full Text] [Related]

  • 8. OKT3 prophylaxis in cadaveric kidney transplant recipients with delayed graft function.
    Cohen DJ, Benvenisty AI, Cianci J, Hardy MA.
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):19-27. PubMed ID: 2510507
    [Abstract] [Full Text] [Related]

  • 9. OKT3 prophylaxis versus conventional drug therapy: single-center perspective, part of a multicenter trial.
    Kahana L, Narvarte J, Ackermann J, LeFor W, Weinstein S, Wright C, deQuesada A, Baxter J, Shires D.
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):5-9. PubMed ID: 2510510
    [Abstract] [Full Text] [Related]

  • 10. A randomized clinical trial of induction therapy with OKT3 in kidney transplantation.
    Norman DJ, Kahana L, Stuart FP, Thistlethwaite JR, Shield CF, Monaco A, Dehlinger J, Wu SC, Van Horn A, Haverty TP.
    Transplantation; 1993 Jan; 55(1):44-50. PubMed ID: 8420063
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
    Prieto M, Lake KD, Pritzker MR, Jorgensen CR, Arom KV, Love KR, Emery RW.
    J Heart Lung Transplant; 1991 Jan; 10(6):901-11. PubMed ID: 1661608
    [Abstract] [Full Text] [Related]

  • 14. Influence of low-dose cyclosporine on the outcome of treatment with OKT3 for acute renal allograft rejection.
    Hricik DE, Zarconi J, Schulak JA.
    Transplantation; 1989 Feb; 47(2):272-7. PubMed ID: 2493175
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of OKT3 in kidney, pancreas, and liver transplantation.
    D'Alessandro AM, Pirsch JD, Melzer JS, Sollinger HW, Kalayoglu M, Reed A, Knechtle SJ, Belzer FO.
    Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
    [No Abstract] [Full Text] [Related]

  • 19. OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation.
    Hegewald MG, O'Connell JB, Renlund DG, Lee HR, Burton NA, Karwande SV, Jones KW, Lassetter JE, Bristow MR.
    J Heart Transplant; 1989 Aug; 8(4):303-9; discussion 309-10. PubMed ID: 2504897
    [Abstract] [Full Text] [Related]

  • 20. Treatment with OKT3 and cyclosporine for acute allograft rejection.
    Schulak JA, Mayes JT, Hricik DE.
    Transplant Proc; 1991 Aug; 23(4):2119-22. PubMed ID: 1908150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.